SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is rallying following a strategic partnership with NVIDIA to deploy AI infrastructure and a potential $2.1 billion equity investment, which has overshadowed investor concerns regarding a quarterly earnings miss. The community remains divided between long-term bulls betting on the company's transition to a major AI infrastructure player and skeptics calling the timing of the news a distraction from weak financial results and ongoing dilution fears.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing significant volatility surrounding its earnings report as investors weigh explosive revenue growth and a massive backlog against concerns over high capital expenditures and debt. The community is sharply divided between bulls prioritizing long-term AI infrastructure scale and bears highlighting the company's persistent cash burn and a historical pattern of post-earnings selling.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant volatility as investors debate the company's long-term growth potential and high cash burn following an earnings report that featured record revenue but missed earnings expectations. While some in the community highlight the stock's lack of debt and aggressive enterprise expansion as signs of future dominance, others are frustrated by management's communication and the lack of immediate profitability, leading to heavy discussion around potential short-squeeze setups and retail sentiment.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense investor focus as the company reports earnings that highlight its pivot to an 'Opendoor 2.0' model, featuring improved unit economics and a clear path toward EBITDA profitability. While bullish shareholders are cheering the turnaround progress and acquisition growth, the community remains divided as traders debate whether the stock's future hinges on long-term execution or if it will face the typical volatility and 'sell the news' pressure common with the symbol.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the market anticipates a shift in leadership at the FDA's Center for Biologics Evaluation and Research, with investors closely watching for the appointment of a new director to potentially accelerate approval of its DMD therapy. The community remains intensely focused on the upcoming PDUFA date and the potential for a broad, high-value label, viewing recent volatility as a tactical shakeout by institutional players rather than a fundamental shift in the drug's prospects.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is experiencing extreme volatility and downward pressure as investors grow increasingly frustrated with management and the lack of clarity regarding potential AI partnerships or audit concerns. The community remains deeply divided, with some hoping for a short squeeze or positive earnings surprise, while others are aggressively closing positions and criticizing the company's long-term performance.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending as investors focus on its Q1 earnings report, with significant community discussion centered on its record-breaking backlog and expanding role in national defense, including new hypersonic launch contracts with Anduril. The broader investor narrative is bullish, viewing the company as a key structural player in the aerospace and space infrastructure sector, with many participants actively debating the impact of the upcoming Neutron rocket debut and the potential upside of the company's dual-use commercial and defense portfolio.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as investors weigh an upcoming earnings report against the broader crypto market's momentum and renewed legislative optimism surrounding the Clarity Act. The community is actively debating the company's recent workforce restructuring while focusing on whether institutional interest and stablecoin infrastructure can drive a meaningful breakout from current price levels.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is seeing intense volatility as the market debates whether the recent rally, driven by AI infrastructure demand and capacity expansion, is justified given the company's mixed earnings report and ongoing margin pressures. While some investors are highlighting the long-term growth potential of its 800G product ramp and hyperscaler partnerships, skeptics are actively warning of potential downside, citing stretched valuations and concerns over profitability.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is facing intense investor scrutiny as shareholders demand clarity on revenue and contract execution ahead of its upcoming earnings report. The discourse is marked by skepticism over management's communication style compared to sector peers, with the community focused on whether the company can finally convert its defense partnerships and expanded manufacturing capacity into tangible financial results.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jennison Associates LLC Has $40.56 Million Position in Palvella Therapeutics, Inc. $PVLA

Jennison Associates LLC boosted its position in shares of Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) by 262.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 387,483 shares of the company's stock after purchasing an additional...

Palvella Therapeutics (PVLA) Expected to Announce Quarterly Earnings on Thursday

Palvella Therapeutics (NASDAQ:PVLA) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-palvella-therapeutics-stock...

Palvella Therapeutics, Inc. (NASDAQ:PVLA) Given Consensus Recommendation of "Moderate Buy" by Analysts

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) has received an average rating of "Moderate Buy" from the fifteen ratings firms that are presently covering the stock, Marketbeat reports...

Palvella Therapeutics (NASDAQ:PVLA) Shares Gap Up - What's Next?

Palvella Therapeutics (NASDAQ:PVLA) Shares Gap Up - Time to Buy...

Deltec Asset Management LLC Has $251,000 Stock Position in Palvella Therapeutics, Inc. $PVLA

Deltec Asset Management LLC decreased its position in Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) by 80.8% in the 4th quarter, according to the company in its most recent filing with the...

Palvella Therapeutics (NASDAQ:PVLA) Downgraded by Wall Street Zen to "Sell"

Wall Street Zen downgraded Palvella Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Palvella Therapeutics, Inc. (NASDAQ:PVLA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) has been assigned an average rating of "Moderate Buy" from the fifteen research firms that are covering the company, MarketBeat.com...

Lifesci Capital Brokers Decrease Earnings Estimates for PVLA

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) - Investment analysts at Lifesci Capital lowered their FY2026 earnings per share (EPS) estimates for Palvella Therapeutics in a note issued to...

HC Wainwright Brokers Decrease Earnings Estimates for PVLA

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) - Equities research analysts at HC Wainwright reduced their FY2026 EPS estimates for shares of Palvella Therapeutics in a research note issued...

What is HC Wainwright's Estimate for PVLA Q1 Earnings?

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings estimates for Palvella Therapeutics in a report issued on...

$PVLA Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$1.20 down -62.16% YoY
• Palvella Therapeutics believes its cash and short-term investments of $261.9M as of March 31, 2026, will fund operations for at least twelve months; however, additional capital may be needed thereafter.

Stocktwits

Palvella Therapeutics Inc

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$1.20 down -62.16% YoY
• Palvella Therapeutics believes its cash and short-term investments of $261.9M as of March 31, 2026, will fund operations for at least twelve months; however, additional capital may be needed thereafter.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

Current Price	$113.26
Prev Close	$130.17
Open	$129.05
Dividend Yield	0.00%
50-Day Moving Average	$126.62
Beta	1.10
Avg. Volume	222,471.02
PE Ratio	-35.11

52-Week High	$151.18
52-Week Low	$20.20
Market Capitalization	$1.86B
EPS (Annual)	-$3.71
Price to Book	57.59
Revenue Per Employee	$0.00

PVLA
Palvella Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PVLA News

PVLAPalvella Therapeutics Inc